Aryl butenes active against K562 cells and lacking tyrosinase inhibitory activity as new leads in the treatment of leukemia.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Pascal Pigeon Girish Kumar Gupta Siden Top |
| Publication date | January 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |